Pancreatic Biomarker Bank ("Panc-Bank")

Condition: Pancreatic diseases

Eligibility

Key Inclusion Criteria

  • Patient who is or will be scheduled for a blood draw, tissue biopsy, and/or biofluid collection at Cedars-Sinai for clinical diagnostic purposes and
  • Adult patient with pancreatic disease seen at Cedars-Sinai under the care of a Panc-Bank study investigator who is the patient's treating physician

Key Exclusion Criteria

  • Children
  • Pregnant women

Full Study Name

Biomarker Studies for Pancreatic Diseases Using IRB #4201 Repository for Clinical Data and the Collection of Liver, Hepatobiliary/Pancreatic Tissue, Blood and Bile for Hepatology and Liver Transplantation Research (IRB no. 41571)

Summary

The purpose of the Pancreatic Biomarker Bank ("Panc-Bank") is to identify biomarkers that influence an individual's risk of developing pancreatic diseases. A biomarker is a biological molecule found in blood, other body fluids, or tissues that may be a sign of a condition or disease. Through the Panc-Bank, researchers also aim to discover new tests and treatments for pancreatic diseases, as well as further their understanding of these diseases.

The Panc Bank will collect patients' blood, tissue, and biofluid samples to be used for future research; these materials will be studied together with clinical information from medical records.

Principal Investigator

Stephen Pandol, MD

Contact
Stephen Pandol, MD
Phone: 310-502-0770
Email: stephen.pandol@cshs.org